# Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer

> **NCT00489359** · PHASE1,PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 86 (actual)

## Conditions studied

- Ovarian Cancer
- Primary Peritoneal Cancer

## Interventions

- **DRUG:** Pemetrexed - Phase 1
- **DRUG:** Carboplatin - Phase 1
- **DRUG:** Pemetrexed - Phase 2
- **DRUG:** Carboplatin - Phase 2

## Key facts

- **NCT ID:** NCT00489359
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2011-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489359, "Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00489359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*